MedCity News

Epic MyChart Phishing Scam Hits Health Systems: What Providers Should Do

FDA Nod for Inflammation Drug Notches Wins for Rare Disease Patients, Roivant’s Biz Strategy

Roivant Sciences subsidiary Priovant Therapeutics received FDA approval for Lisraya as a treatment for the rare inflammatory disorder dermatomyositis. Licensed from Pfizer, this once-daily pill designed to block JAK1 and TYK2 proteins is also in clinical development for three additional rare immunological disorders, each with blockbuster potential.

By Frank Vinluan

MedCity Influencers

The Silent Epidemic: Why Diabetic Foot Ulcers Have Been Overlooked for Three Decades

Chronic wounds demand clinicians willing to act outside of their defined role, not because the system incentivizes it, but because without it, the wound will not heal.

By Ned Swanson

MedCity Influencers

A robot hand and a doctor's hand with a medical technology icon. A concept for human and AI collaboration in healthcare, robotic-assisted surgery, and the future of medicine.

Reading the Body’s Signals: AI’s Ultimate Healthcare Opportunity

We are on the cusp of an age of anticipatory medicine, an explosion in our ability to read the body's signals and catch the killers before they do their damage.

By Murray Brozinsky

Latest Video

Latest News

BioPharma, Pharma

AstraZeneca, Amgen Drug Moves Closer to Competing With Dupixent in a New Indication

AstraZeneca and Amgen drug Tezspire met the goals of a Phase 3 test in eosinophilic esophagitis (EoE), a chronic disorder whose only approved biologic therapy is Sanofi’s Dupixent. An approval for Tezspire in EoE would be its third indication, bolstering sales of the blockbuster product.

By Frank Vinluan

Health Tech, Providers

Female doctor and nurse conferring at reception desk in doctor's office

Datavant’s New Platform Could Cut Record Retrieval Time from Days to Hours

Datavant launched a new provider exchange platform, which replaces fax-based record requests with a digital workflow. It aims to give care teams real-time visibility into request status while easing the administrative burden on clinical staff.

By Katie Adams

MedCity Influencers

Precision Medicine Transformed Oncology —It’s Time to Do the Same for Sepsis

It’s time we reignite treatment development for sepsis and other immune-mediated conditions that strike when patients are most vulnerable.

By Bobby Reddy, Jr. and Dr. Nathan Shapiro

Events, Pharma

What Do the Latest Iteration of Consumer Drug Platforms Offer?

Consumer drug platforms and how they fit into the rise of the consumer in healthcare will be part of the conversation at INVEST Digital Health, scheduled for October 29 in Dallas. Register today!

By Stephanie Baum

Health Tech

Little pink ceramic piggy bank pattern on the left side on yellow background. Concept of saving money, savings.

Onos Health Raises $17M to Expand AI-Powered Behavioral Health Platform

Onos Health's Series A funding round was led by Costanoa, with support from Flare Capital Partners and CVS Health Ventures.

By Marissa Plescia

Where Will AI Deployment Benefit Payers the Most?

We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.

By MedCity News

Devices & Diagnostics, Health Tech

Hackers work secretly in secret rooms. Mysterious colored lights Breaking into personal security and various agencies in the world . Wanted Hacker using computer for hacking in the cyber data center .

Cyberattack Disrupts Boston Scientific’s Operations: 7 Things to Know

Boston Scientific disclosed a cyberattack disrupting its global IT systems and order shipping capabilities, with the company unable to provide a timeline for when normal operations will resume. The disclosure adds the medical device giant to a growing list of medtech companies — including Stryker, Medtronic and Abbott — hit by major cyberattacks this year.

By Katie Adams

BioPharma, Pharma

Revolution Medicines Receives Landmark FDA Drug Approval in Pancreatic Cancer

FDA approval of Revolution Medicines’ daraxonrasib, brand name Rasonque, makes the molecule the first RAS inhibitor approved for treating pancreatic adenocarcinoma, the most common type of pancreatic cancer. The speedy regulatory nod specifically covers advanced cases of this type of cancer, which has had limited treatment options.

By Frank Vinluan

MedCity Influencers

Stop Pitching the Institute — Pitch the Stack

Health-tech pilots don't usually fail because the product is bad. They fail because the system was never wired to absorb it.

By Mitchell Frye

Artificial Intelligence, Health Tech, Consumer / Employer, Legal

Woman wearing smart ring on her hand. Concept sport and healthy lifestyle

Why Oura’s Sleep-Tracking Lawsuit Is Really About Trust

A new class action lawsuit accuses Oura of overstating its smart ring's sleep tracking accuracy, arguing the device relies on AI-generated estimates rather than the clinical measurements needed for true sleep staging. The case is reigniting questions about how much precision consumers should expect from AI-powered health wearables.

By Katie Adams

Consumer / Employer

Rising Healthcare costs and higher health care prices as increase in medication and prescription medications or unaffordable hospital bills represented by a Doctor stethoscope and upward arrow.

Business Group on Health: Employer Healthcare Costs Projected to Rise 9.2% in 2027

Employers expect healthcare costs to rise 9.2% in 2027 as they seek ways to curb rising hospital and pharmacy costs.

By Marissa Plescia

BioPharma, Pharma

J&J’s Imaavy Becomes First FDA-Approved Therapy for Rare Form of Anemia

Johnson & Johnson antibody drug Imaavy expanded its label to include the treatment of warm autoimmune hemolytic anemia (wAIHA). Projected to become a blockbuster seller across multiple indications, Imaavy was first approved last year for treating generalized myasthenia gravis.

By Frank Vinluan

MedCity Influencers

Before You Sign That AI Contract: 7 Questions Every Healthcare CFO Should Ask

Here's how finance leaders can evaluate AI investments in revenue cycle management before committing budget, and the risk exposure most vendor pitches leave out.

By Purnendu Bala

Health Tech, Hospitals, Providers

Scalable to any size. Vector illustration file.

4 Patients Injured After Drug Mix-Up at Ascension Hospital in Nashville

A pharmacy error at an Ascension hospital in Nashville left four joint replacement patients injected with potassium phosphate instead of spinal anesthetic. The mix-up paralyzed one patient and harmed the other three. The Tennessee Bureau of Investigation is now probing the case.

By Katie Adams

Health Tech

Amazon Taps Expressable for Health Benefits Connector

Expressable has joined Amazon’s Health Benefits Connector to help families access virtual speech therapy through their insurance.

By Marissa Plescia

BioPharma, Pharma

Roche Gains Rights to Hanmi Obesity Drug That Reduces Fat, Preserves Muscle

Hanmi Pharmaceutical’s drug is designed to activate a receptor in skeletal muscle to both increase muscle mass and reduce fat. This engineered peptide gives Roche a clinical-stage asset that addresses a different target than the other obesity drugs in its pipeline.

By Frank Vinluan